translation please, page-12

"Despite having several unique advantages over currently available products,the Unitract 1mL syringes face significant competition from a number of large and established companies."

I am a long term holder but have to agree with Sonpa here. When the CEO says something like that, it means no success yet in selling the 1ml. As people here have been saying all along, our hopes are on Sanofi putting in the big orders for the prefill, but it would have been nice to have some icing on the cake. mmm, cake with no icing, ok but a bit dry.

UNS must have been expecting a little bit of cashflow from the 1ml so hope this doesnt leave a hole in the budget.